Cerus Corporation ( CERS) - Key Metrics
CERS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.29 | -$0.01 | -$0.01 | -$0.02 |
| 2026Q1 | $0.28 | -$0.01 | -$0.02 | -$0.02 |
| 2025Q4 | $0.30 | -$0.01 | $0.03 | $0.03 |
| 2025Q3 | $0.27 | $0 | $0.01 | $0 |
| 2025Q2 | $0.27 | -$0.03 | -$0.01 | -$0.02 |
CERS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -49.66 |
| 2026Q1 | 0% | -45.50 |
| 2025Q4 | 0% | -45.18 |
| 2025Q3 | 0% | -3975 |
| 2025Q2 | 0% | -11.83 |
CERS
Price: $2.28
52 week price:
Earnings Per Share: -0.03 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 1.8 million
Ebitda: -11.8 millionMarket Capitalization: 471.6 million